share_log

The Oncology Institute, Inc. (NASDAQ:TOIIW) COO Matthew P. Miller Buys 73,684 Shares of Stock

The Oncology Institute, Inc. (NASDAQ:TOIIW) COO Matthew P. Miller Buys 73,684 Shares of Stock

腫瘤研究所股份有限公司(NASDAQ:TOIW)首席運營官馬修·米勒收購 73,684 股股票
Defense World ·  2022/12/21 06:31

The Oncology Institute, Inc. (NASDAQ:TOIIW – Get Rating) COO Matthew P. Miller bought 73,684 shares of Oncology Institute stock in a transaction on Friday, December 16th. The stock was acquired at an average cost of $0.95 per share, with a total value of $69,999.80. Following the acquisition, the chief operating officer now owns 175,325 shares in the company, valued at approximately $166,558.75. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

腫瘤研究所,公司(納斯達克:TOIIW-GET評級)首席運營官馬修·P·米勒在12月16日星期五的一筆交易中購買了73,684股腫瘤研究所的股票。該股是以每股0.95美元的平均成本收購的,總價值為69,999.80美元。收購完成後,首席運營官現在擁有該公司175,325股股票,價值約166,558.75美元。此次收購是在提交給美國證券交易委員會的一份檔案中披露的,該檔案可通過這個環節.

Oncology Institute Stock Performance

腫瘤研究所股票表現

TOIIW stock opened at $0.06 on Wednesday. The Oncology Institute, Inc. has a 1 year low of $0.06 and a 1 year high of $1.50. The stock's fifty day moving average price is $0.32 and its 200-day moving average price is $0.56.

週三,TOIIW股價開盤報0.06美元。腫瘤學研究所,Inc.的一年低點為0.06美元,一年高位為1.50美元。該股的50日移動均線價格為0.32美元,200日移動均線價格為0.56美元。

Get
到達
Oncology Institute
腫瘤學研究所
alerts:
警報:

Hedge Funds Weigh In On Oncology Institute

對沖基金參與腫瘤學研究所

A hedge fund recently raised its stake in Oncology Institute stock. Wolverine Asset Management LLC boosted its stake in shares of The Oncology Institute, Inc. (NASDAQ:TOIIW – Get Rating) by 29.0% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 118,666 shares of the company's stock after acquiring an additional 26,700 shares during the quarter. Wolverine Asset Management LLC's holdings in Oncology Institute were worth $59,000 as of its most recent SEC filing.

一家對沖基金最近增持了腫瘤學研究所的股票。金剛狼資產管理有限責任公司根據其向美國證券交易委員會(美國證券交易委員會)披露的最新資訊,在第二季度將其在腫瘤研究所公司(JD:TOIIW-GET評級)的股份增加了29.0%。該基金在本季度增持了26,700股後,持有118,666股該公司股票。截至最近提交的美國證券交易委員會申報檔案,金剛狼資產管理有限公司持有的腫瘤學研究所股份價值59,000美元。

About Oncology Institute

關於腫瘤學研究所

(Get Rating)
(獲取評級)

The Oncology Institute, Inc, an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants for cancer patients.

腫瘤學研究所是一家腫瘤學公司,在美國提供內科腫瘤學服務。它的服務包括醫生服務、內部輸液和藥房、臨床試驗服務、門診幹細胞移植和輸血計劃以及患者支持。該公司還提供和管理臨床試驗服務,如管理臨床試驗、姑息治療計劃和癌症患者的幹細胞移植。

Recommended Stories

推薦故事

  • Get a free copy of the StockNews.com research report on Oncology Institute (TOIIW)
  • Is There a Prize in Store for Kellogg Shareholders?
  • Will AMC's Troubles Affect Its Landlord, EPR Properties?
  • General Mills Retreats To More Attractive Territory
  • Will Tesla Shares Rally If Musk Steps Down From Twitter?
  • 5 Down But Not Out Stocks To Watch For 2023
  • 免費獲取StockNews.com腫瘤學研究所研究報告(TOIIW)
  • 凱洛格的股東有店內獎品嗎?
  • AMC的麻煩會影響其房東EPR Properties嗎?
  • 通用磨坊撤退至更具吸引力的地區
  • 如果馬斯克退出Twitter,特斯拉的股價會上漲嗎?
  • 2023年值得關注的5個下跌但不是下跌的股票

Receive News & Ratings for Oncology Institute Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncology Institute and related companies with MarketBeat.com's FREE daily email newsletter.

接受腫瘤學研究所每日新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收腫瘤學研究所和相關公司的最新新聞和分析師評級的每日簡明摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論